Research Solutions (NASDAQ: RSSS) turns Q2 profit with ARR up 13.9% and margin gains

Rhea-AI Filing Summary

Research Solutions, Inc. reported a profitable fiscal second quarter 2026, reversing a prior-year loss. Net income was $547,000, or $0.02 per diluted share, compared with a net loss of $2.0 million a year earlier. Adjusted EBITDA rose to $1.3 million, up 35.6%.

Total revenue was $11.8 million, down 1.0%, as strong growth in higher-margin Platform subscriptions offset weaker Transaction revenue. Platform revenue grew 13.6% to $5.2 million, and total annual recurring revenue reached $21.8 million, up 13.9% year-over-year. Gross margin expanded to 52.4%, while operating expenses declined 5.1%, supporting improved profitability and cash generation.

Positive

• Return to profitability and strong EBITDA growth: Net income reached $546,919 versus a $1,980,234 loss a year earlier, and Adjusted EBITDA rose 35.6% to $1,305,337, indicating materially improved operating performance.
• Recurring revenue and margin expansion: Total ARR increased 13.9% to $21,760,370, while gross margin improved to 52.4% from 48.9%, driven by growth in higher-margin Platform subscription revenue.

Negative

• None.

Insights

Equity research analyst

Company delivers profit, stronger margins, and ARR growth despite flat revenue.

Research Solutions posted net income of $546,919 for the quarter ended December 31, 2025, versus a loss of $1,980,234 a year earlier. Revenue was essentially flat at $11,792,651, but the mix shifted toward its higher-margin Platform subscriptions.

Platform revenue rose 13.6% to $5,224,845, while Transaction revenue declined 10.2%. This mix, combined with cost discipline, lifted total gross margin to 52.4% and reduced total operating expenses by 5.1%. Adjusted EBITDA increased to $1,305,337, up 35.6%.

Annual recurring revenue climbed to $21,760,370, up 13.9% year-over-year, reflecting 47 incremental Platform deployments and higher average sales price. Cash from operating activities of $2,491,176 for the six months ended December 31, 2025 supports ongoing investment in sales, marketing, and product while maintaining balance sheet flexibility.

false 0001386301 0001386301 2026-02-12 2026-02-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report:

(Date of earliest event reported)

February 12, 2026

Research Solutions, Inc.

(Exact name of registrant as specified in its charter)

Nevada

(State or other Jurisdiction of Incorporation)

1-39256		11-3797644
(Commission File Number)		(IRS Employer Identification No.)

N/A¹

(Address of Principal Executive Offices and zip code)

(310) 477-0354

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class	Trading Symbol(s)	Name of each Exchange on which registered
Common stock, $0.001 par value	RSSS	The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company     ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

¹ In November 2019, we became a fully remote company. Accordingly, we do not currently have principal executive offices. Our mailing address is 10624 S. Eastern Ave., Ste. A-614, Henderson, NV 89052.

Item 2.02 Results of Operations and Financial Condition.

On February 12, 2026, the Registrant announced its financial results for the second quarter ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

	Exhibit Number	Description
	99.1	Press Release issued February 12, 2026 entitled “Research Solutions Reports Second Quarter Fiscal Year 2026 Results”.
	104	Cover Page Interactive Data File (embedded as Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RESEARCH SOLUTIONS, INC.
Date: February 12, 2026	By:	/s/ David Kutil
		David Kutil
		Interim Chief Financial Officer

Exhibit 99.1

FOR IMMEDIATE RELEASE

 

Research Solutions Reports Second Quarter Fiscal Year 2026 Results

Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA 

HENDERSON, Nev., February 12, 2026 — Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025.

Fiscal Second Quarter 2026 Summary (compared to prior-year quarter)

· Annual Recurring Revenue (“ARR”) up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.

· Forty-seven net new deployments in the quarter reflect one of our best results and sustained momentum in new B2B customer acquisition.

· Net income of $547,000, or $0.02 per diluted share, compared to net loss of $2.0 million or ($0.07) per share.

· Adjusted EBITDA increased 36% to $1.3 million. On a trailing twelve-month ("TTM") basis, the Company has now generated Adjusted EBITDA of $5.8 million or 11.8% of revenue for the same period.

· Net B2B ARR growth of $560,000 represents the best organic second quarter performance in Company history.

· Gross profit up 6% to $6.2 million. Total gross margin improved 350 basis points to 52.4%.

· Platform revenue up 14% to $5.2 million. Platform revenue accounted for 44% of total revenue as compared to 39% in the prior-year quarter.

· Total revenue was $11.8 million compared to $11.9 million in the prior year, as strong B2B revenue growth has not yet fully offset softness in transactions revenue.

“Our second quarter results reflect strong growth within our B2B Platforms business through forty-seven net new deployments in the quarter and Platforms continues to represent a larger portion of our total revenue mix. In addition, the average sales price for our Platform increased more than six percent year-over-year as we signed larger deals and as existing customers adopt more of our SaaS and AI solutions,” said Roy W. Olivier, President and CEO of Research Solutions. “Our business continues to generate strong operating cash flow and Adjusted EBITDA, allowing us to reinvest in sales and marketing to accelerate growth while maintaining financial flexibility. We continue to manage the business with a long-term focus to drive value for our shareholders.”

Fiscal Second Quarter 2026 Results

Total revenue was $11.8 million, compared to $11.9 million in the year-ago quarter. Platform revenue growth was offset by a decline in transactions revenue.

Platform subscription revenue for the quarter was $5.2 million, a 14% year-over-year increase from the prior-year period. The increase was primarily due to organic growth in the core B2B platform, due to a mix of new logo generation as well as upsells and cross-selling into existing customers. The quarter ended with annual recurring revenue of $21.8 million, up 14% year-over-year (see the Company’s definition of annual recurring revenue below).

Transaction revenue was $6.6 million, compared to $7.3 million in the second quarter of fiscal 2025. The decrease was due to the impact of a known customer that churned earlier and a few larger customers that saw significant declines in volume. The transaction active customer count for the quarter was 1,321, compared to 1,384 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

Total gross margin improved 350 basis points from the prior-year quarter to 52.4%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, including the expansion of the gross margin for that business.

Total operating expenses were $5.4 million, compared to $5.7 million in the second quarter of fiscal 2025. The decrease was primarily related to reduced general and administrative and stock-based compensation expenses offset in part by increased sales and marketing expenses.

Net income in the fiscal second quarter was $547,000, or $0.02 per diluted share, compared to a net loss of $2 million, or ($0.07) per share, in the prior-year quarter. Adjusted EBITDA was $1.3 million, compared to $963,000 in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

Conference Call

Management will host the conference call, followed by a question-and-answer period.

Date: Thursday, February 12, 2026

Time: 5:00 p.m. ET (2:00 p.m. PT)

Dial-in number: 1-203-518-9708

Conference ID: RESEARCH

The conference call will be broadcast live and available for replay until March 12, 2026 by dialing 1-412-317-6671 and using the replay ID 11160799, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.

Fiscal Second Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter

		Quarter Ended December 31,																Six Months Ended December 31,
		2025				2024				Change				% Change				2025				2024				Change				% Change
Revenue:
Platforms		$	5,224,845			$	4,601,257			$	623,588				13.6	%		$	10,345,685			$	8,930,902			$	1,414,783				15.8	%
Transactions			6,567,806				7,312,962				(745,156	)			-10.2	%			13,759,151				15,027,799				(1,268,648	)			-8.4	%
Total Revenue			11,792,651				11,914,219				(121,568	)			-1.0	%			24,104,836				23,958,701				146,135				0.6	%
Gross Profit:
Platforms			4,602,184				3,981,415				620,769				15.6	%			9,112,649				7,763,893				1,348,756				17.4	%
Transactions			1,574,766				1,839,678				(264,912	)			-14.4	%			3,289,599				3,823,076				(533,477	)			-14.0	%
Total Gross Profit			6,176,950				5,821,093				355,857				6.1	%			12,402,248				11,586,969				815,279				7.0	%
Gross profit as a % of revenue:
Platforms			88.1	%			86.5	%			1.6	%							88.1	%			86.9	%			1.1	%
Transactions			24.0	%			25.2	%			-1.2	%							23.9	%			25.4	%			-1.5	%
Total Gross Profit			52.4	%			48.9	%			3.5	%							51.5	%			48.4	%			3.1	%
Operating Expenses:
Sales and marketing			1,648,597				1,343,087				305,510				22.7	%			3,315,422				2,533,494				781,928				30.9	%
Technology and product development			1,602,421				1,506,849				95,572				6.3	%			3,012,572				2,879,607				132,965				4.6	%
General and administrative			1,620,595				2,008,201				(387,606	)			-19.3	%			3,295,954				3,938,377				(642,423	)			-16.3	%
Depreciation and amortization			316,425				306,233				10,192				3.3	%			632,491				618,328				14,163				2.3	%
Stock-based compensation			213,449				534,322				(320,873	)			-60.1	%			425,931				952,311				(526,380	)			-55.3	%
Foreign currency translation loss (gain)			36,112				29,554				6,558				22.2	%			18,856				(74,686	)			93,542				-125.2	%
Total Operating Expenses			5,437,599				5,728,246				(290,647	)			-5.1	%			10,701,226				10,847,431				(146,205	)			-1.3	%
Income from operations			739,351				92,847				646,504				696.3	%			1,701,022				739,538				961,484				-130.0	%
Other expense:
Other expense			(183,572	)			(2,057,887	)			1,874,315				-91.1	%			(374,625	)			(1,989,362	)			1,614,737				-81.2	%
Provision for income taxes			(8,859	)			(15,194	)			6,335				-41.7	%			(30,090	)			(61,406	)			31,316				-51.0	%
Total Other Expense:			(192,431	)			(2,073,081	)			1,880,650				-90.7	%			(404,715	)			(2,050,768	)			1,646,053				-80.3	%
Net income (loss)		$	546,920			$	(1,980,234	)			2,527,154				-127.6	%		$	1,296,307			$	(1,311,230	)			2,607,537				-198.9	%
Adjusted EBITDA		$	1,305,337			$	962,956			$	342,381				35.6	%		$	2,778,300			$	2,235,491			$	542,809				24.3	%

		Quarter Ended December 31,																Six Months Ended December 31,
		2025				2024				Change				% Change				2025				2024				Change				% Change
Platforms:
B2B ARR (Annual recurring revenue*):
Beginning of Period		$	14,758,472			$	12,187,834			$	2,570,637				21.1	%		$	14,197,598			$	12,060,201			$	2,137,397				17.7	%
Incremental ARR			560,482				550,422				10,060				1.8	%			1,121,356				678,055				443,301				65.4	%
End of Period		$	15,318,954			$	12,738,256			$	2,580,697				20.3	%		$	15,318,954			$	12,738,256			$	2,580,698				20.3	%
Deployments:
Beginning of Period			1,185				1,029				156				15.2	%			1,171				1,021				150				14.7	%
Incremental Deployments			47				61				(14	)			-23.0	%			61				69				(8	)			-11.6	%
End of Period			1,232				1,090				142				13.0	%			1,232				1,090				142				13.0	%
ASP (Average sales price):
Beginning of Period		$	12,454			$	11,844			$	610				5.2	%		$	12,124			$	11,812			$	312				2.6	%
End of Period		$	12,434			$	11,686			$	748				6.4	%		$	12,434			$	11,686			$	748				6.4	%
B2C ARR (Annual recurring revenue*):
Beginning of Period		$	6,535,197			$	5,430,795			$	1,104,402				20.3	%		$	6,721,356			$	5,363,129			$	1,358,227				25.3	%
Incremental ARR			(93,781	)			940,586				(1,034,367	)			-110.0	%			(279,940	)			1,008,252				(1,288,192	)			-127.8	%
End of Period		$	6,441,416			$	6,371,381			$	70,035				1.1	%		$	6,441,416			$	6,371,381			$	70,035				1.1	%
Total ARR (Annualized recurring revenue):		$	21,760,370			$	19,109,637			$	2,650,732				13.9	%		$	21,760,370			$	19,109,637			$	2,650,733				13.9	%
Transaction Customers:
Corporate customers			1,326				1,051				275				26.2	%			1,200				1,063				137				12.9	%
Academic customers			324				333				(9	)			-2.7	%			320				325				(5	)			-1.5	%
Total customers			1,650				1,384				266				19.2	%			1,520				1,388				132				9.5	%

* Annual Recurring Revenue (Non-GAAP Measure) - the value of contracted platform subscription recurring revenue normalized to a one year period. For B2C, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by 12.

Active Customer Accounts, Transactions and Annual Recurring Revenue

The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

The Company defines annual recurring revenue (“ARR”) as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

Use of Non-GAAP Measure – Adjusted EBITDA

Research Solutions’ management evaluates and makes operating decisions using various financial metrics. In addition to the Company’s GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company’s operating results.

The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):

		Quarter Ended December 31,																Six Months Ended December 31,
		2025				2024				Change				% Change				2025				2024				Change				% Change
		$	546,920			$	(1,980,234	)		$	2,527,154				-127.6	%		$	1,296,307			$	(1,311,230	)		$	2,607,537				-198.9	%
																											-
Other expense			183,572				2,057,887				(1,874,315	)			-91.1	%			374,625				1,989,362				(1,614,737	)			-81.2	%
Foreign currency translation loss (gain)			36,112				29,554				6,558				22.2	%			18,856				(74,686	)			93,542				-125.2	%
Provision for income taxes			8,859				15,194				(6,335	)			-41.7	%			30,090				61,406				(31,316	)			-51.0	%
Depreciation and amortization			316,425				306,233				10,192				3.3	%			632,491				618,328				14,163				2.3	%
Stock-based compensation			213,449				534,322				(320,873	)			-60.1	%			425,931				952,311				(526,380	)			-55.3	%
		$	1,305,337			$	962,956			$	342,381				35.6	%		$	2,778,300			$	2,235,491			$	542,809				-24.3	%

About Research Solutions

Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com

Important Cautions Regarding Forward-Looking Statements

Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company’s prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to officially release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

		December 31,				June 30,
		2025				2025
Assets
Current assets:
Cash and cash equivalents		$	12,262,780			$	12,227,312
Accounts receivable, net of allowance of $79,869 and $182,324, respectively			5,661,171				7,191,234
Prepaid expenses and other current assets			708,075				580,257
Prepaid royalties			42,155				925
Total current assets			18,674,181				19,999,728
Non-current assets:
Property and equipment, net of accumulated depreciation of $992,832 and $964,883, respectively			65,236				60,769
Intangible assets, net of accumulated amortization of $3,347,683 and $2,736,773, respectively			9,130,484				9,686,241
Goodwill			16,372,979				16,372,979
Deposits and other assets			1,000				957
Total assets		$	44,243,880			$	46,120,674
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses		$	6,397,476			$	7,443,757
Deferred revenue			9,916,853				10,702,120
Contingent earnout liability, current portion			7,295,596				7,363,152
Total current liabilities			23,609,925				25,509,029
Non-current liabilities:
Contingent earnout liability, long-term portion			3,405,356				6,683,488
Total liabilities			27,015,281				32,192,517
Commitments and contingencies
Stockholders’ equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding			—				—
Common stock; $0.001 par value; 100,000,000 shares authorized; 32,875,476 and 32,479,993 shares issued and outstanding, respectively			32,875				32,480
Additional paid-in capital			41,056,472				39,059,557
Accumulated deficit			(23,747,387	)			(25,043,693	)
Accumulated other comprehensive loss			(113,361	)			(120,187	)
Total stockholders’ equity			17,228,599				13,928,157
Total liabilities and stockholders’ equity		$	44,243,880			$	46,120,674

See notes to condensed consolidated financial statements

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)

(Unaudited)

		Three Months Ended								Six Months Ended
		December 31,								December 31,
		2025				2024				2025				2024
Revenue:
Platforms		$	5,224,845			$	4,601,257			$	10,345,685			$	8,930,902
Transactions			6,567,806				7,312,962				13,759,151				15,027,799
Total revenue			11,792,651				11,914,219				24,104,836				23,958,701
Cost of revenue:
Platforms			622,661				619,842				1,233,036				1,167,009
Transactions			4,993,040				5,473,284				10,469,552				11,204,723
Total cost of revenue			5,615,701				6,093,126				11,702,588				12,371,732
Gross profit			6,176,950				5,821,093				12,402,248				11,586,969
Operating expenses:
Selling, general and administrative			5,121,175				5,422,013				10,068,736				10,229,103
Depreciation and amortization			316,425				306,233				632,491				618,328
Total operating expenses			5,437,600				5,728,246				10,701,227				10,847,431
Income from operations			739,350				92,847				1,701,021				739,538
Other income			95,065				348,999				221,978				417,524
Change in fair value of contingent earnout liability			(278,637	)			(2,406,886	)			(596,603	)			(2,406,886	)
Income (loss) before provision for income taxes			555,778				(1,965,040	)			1,326,396				(1,249,824	)
Provision for income taxes			(8,859	)			(15,194	)			(30,090	)			(61,406	)
Net income (loss)			546,919				(1,980,234	)			1,296,306				(1,311,230	)
Other comprehensive income (loss):
Foreign currency translation			5,859				2,637				6,826				(3,531	)
Comprehensive income (loss)		$	552,778			$	(1,977,597	)		$	1,303,132			$	(1,314,761	)
Basic income (loss) per common share:
Net income (loss) per share		$	0.02			$	(0.07	)		$	0.04			$	(0.04	)
Weighted average common shares outstanding			31,634,575				30,421,808				31,434,725				30,384,339
Diluted income (loss) per common share:
Net income (loss) per share		$	0.02			$	(0.07	)		$	0.04			$	(0.04	)
Weighted average common shares outstanding			32,333,657				30,421,808				32,113,408				30,384,339

See notes to condensed consolidated financial statements

Research Solutions, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

		Six Months Ended
		December 31,
		2025				2024
Cash flow from operating activities:
Net income (loss)		$	1,296,306			$	(1,311,230	)
Adjustment to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization			632,491				618,328
Stock options expense			149,262				88,045
Restricted common stock expense			276,669				864,266
Adjustment to contingent earnout liability			596,603				2,406,886
Changes in operating assets and liabilities:
Accounts receivable			1,530,063				(266,255	)
Prepaid expenses and other current assets			(127,818	)			(98,613	)
Prepaid royalties			(41,230	)			478,169
Accounts payable and accrued expenses			(1,035,903	)			(737,670	)
Deferred revenue			(785,267	)			(170,433	)
Net cash provided by operating activities			2,491,176				1,871,493
Cash flow from investing activities:
Purchase of property and equipment			(24,561	)			(5,404	)
Net cash used in investing activities			(24,561	)			(5,404	)
Cash flow from financing activities:
Proceeds from the exercise of stock options			157,500				—
Common stock repurchases			(39,549	)			(205,278	)
Payment of contingent acquisition consideration - Scite and FIZ			(2,554,394	)			(62,560	)
Net cash used in financing activities			(2,436,443	)			(267,838	)
Effect of exchange rate changes			5,296				2,873
Net increase in cash and cash equivalents			35,468				1,601,124
Cash and cash equivalents, beginning of period			12,227,312				6,100,031
Cash and cash equivalents, end of period		$	12,262,780			$	7,701,155
Supplemental disclosures of cash flow information:
Cash paid for income taxes		$	30,090			$	61,406
Non-cash investing and financing activities:
Contingent consideration accrual on asset acquisition		$	20,981			$	30,198
Common stock issued for Scite earnout payment		$	1,453,428			$	—

See notes to condensed consolidated financial statements

Contact

Steven Hooser or John Beisler

Three Part Advisors

(214) 872-2710

shooser@threepa.com; jbeisler@threepa.com

# # #

FAQ

How did Research Solutions (RSSS) perform financially in Q2 fiscal 2026?

Research Solutions reported net income of $546,919 for Q2 fiscal 2026, compared with a net loss of $1,980,234 a year earlier. Total revenue was $11.8 million, down slightly from $11.9 million, while Adjusted EBITDA rose to $1.3 million.

What were Research Solutions’ revenues by segment in the latest quarter?

In Q2 fiscal 2026, Research Solutions generated $5,224,845 of Platform revenue and $6,567,806 of Transaction revenue. Platform revenue grew 13.6% year-over-year, while Transaction revenue declined 10.2%, leading to nearly flat total revenue of $11,792,651.

How fast is Research Solutions’ annual recurring revenue (ARR) growing?

Total annual recurring revenue reached $21,760,370 at the end of Q2 fiscal 2026, up 13.9% from $19,109,637 a year earlier. B2B ARR ended the period at $15,318,954, and B2C ARR was $6,441,416, both contributing to steady subscription growth.

What happened to Research Solutions’ profit margins this quarter?

Total gross margin improved to 52.4% in Q2 fiscal 2026 from 48.9% a year earlier. The improvement was mainly driven by a higher mix of Platform subscription revenue and better margins in that business, while total operating expenses declined by 5.1%.

Did Research Solutions generate positive cash flow in the first half of fiscal 2026?

Yes. For the six months ended December 31, 2025, Research Solutions generated net cash from operating activities of $2,491,176. This compared with $1,871,493 in the prior-year period, reflecting improved profitability and working capital management.

How many new Platform deployments did Research Solutions add in Q2 fiscal 2026?

Research Solutions added 47 net new Platform deployments during Q2 fiscal 2026. Total deployments ended the period at 1,232, up from 1,090 a year earlier, supporting growth in B2B annual recurring revenue and higher average sales price for its SaaS and AI solutions.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EXHIBIT 99.1 370.6 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.0 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 33.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 21.8 KB